PLC β3 activators belong to a distinct chemical class that plays a crucial role in the regulation of cellular signaling pathways. PLC, which stands for Phospholipase C, is an enzyme involved in signal transduction processes within cells. PLC β3, specifically, is a subtype of this enzyme found in various tissues throughout the body, and it is primarily associated with G-protein coupled receptor (GPCR) signaling. GPCRs are membrane-bound receptors that transmit extracellular signals into the cell, initiating a cascade of intracellular events. When activated, PLC β3 catalyzes the hydrolysis of a membrane phospholipid known as phosphatidylinositol 4,5-bisphosphate (PIP2) into two secondary messengers: inositol trisphosphate (IP3) and diacylglycerol (DAG). These secondary messengers go on to regulate a multitude of downstream processes, including intracellular calcium release and protein kinase C (PKC) activation.
The specific role of PLC β3 activators is to enhance the enzymatic activity of PLC β3, thereby amplifying the cellular responses triggered by GPCR signaling. This activation is achieved through various mechanisms, such as direct binding or modification of the enzyme or its upstream regulators. The consequence of PLC β3 activation is the modulation of various physiological processes, including neurotransmission, smooth muscle contraction, immune cell responses, and hormone secretion. By targeting PLC β3, these activators can influence these processes at the molecular level, making them valuable tools in the study of cell signaling pathways and targets for drug development in various fields.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels and potentially enhancing PLC β3 expression through PKA-mediated pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a vitamin A derivative, regulates gene expression and has been shown to influence the expression of PLC isoforms, possibly including PLC β3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C, possibly leading to increased PLC β3 expression as part of a feedback mechanism. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 regulates calcium homeostasis and cell proliferation, and it may influence the expression of PLC β3 through its receptor-mediated signaling. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid that can modulate gene expression and may influence PLC β3 expression through glucocorticoid receptor signaling. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol, an estrogen, binds to estrogen receptors and can modulate gene expression, potentially leading to increased PLC β3 expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate various signaling pathways, including the PI3K/Akt pathway, possibly leading to an increase in PLC β3 expression. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
H2O2 is involved in oxidative stress responses and cell signaling, and it may modulate the expression of PLC β3 through redox-sensitive pathways. | ||||||
L-3,3′,5-Triiodothyronine, Sodium Salt | 55-06-1 | sc-205725 | 250 mg | $115.00 | ||
T3, an active thyroid hormone, binds to thyroid hormone receptors, influencing gene expression and potentially increasing PLC β3 expression. | ||||||